Disseminated mucormycosis in a paediatric patient: Lichthemia corymbifera successfully treated with combination antifungal therapy.
Mucormycosis is a severe fungal infection that largely affects immunocompromised individuals. It carries a high morbidity and mortality rate and is characterised by extensive angioinvasion and necrosis of host tissue. This case report details success in treating disseminated mucormycosis in a paediatric patient with an underlying haematological malignancy. Treatment included institution of combination antifungal therapy with liposomal amphotericin B and caspofungin, aggressive surgical debridement of infected tissue and reversal of underlying immunosuppression.
Women׳s and Children׳s Hospital: Infectious Diseases and Microbiology Department, 72 King William Road, North Adelaide 5006, Australia.
Anita
A
Campbell
Women׳s and Children׳s Hospital: Infectious Diseases and Microbiology Department, 72 King William Road, North Adelaide 5006, Australia.
Celia
C
Cooper
Women׳s and Children׳s Hospital: Infectious Diseases and Microbiology Department, 72 King William Road, North Adelaide 5006, Australia.
Stephen
S
Davis
Combination antifungal therapy; Lichthemia Corymbifera; Mucormycosis; Neutropenia